13F
中

CRBP CORBUS PHARMACEUTICALS HOLDI

2026Q1 · CUSIP 21833P301 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
105
Δ holders QoQ
+6
Breadth percentile
Top 39%
Whale holders
48
Δ whales
+5
Inst. holding value
$120M
New positions
24
Closed positions
18
Price momentum (1Q)
+32.3%
Put / Call
2/6

Breadth history (34 quarters)

2020Q1: Δ+0 · h=1 2023Q1: Δ+29 · h=30 2023Q2: Δ-1 · h=29 2023Q3: Δ-1 · h=28 2023Q4: Δ+7 · h=35 2024Q1: Δ+48 · h=83 2024Q2: Δ+25 · h=108 2024Q3: Δ+0 · h=108 2024Q4: Δ-7 · h=101 2025Q1: Δ-15 · h=86 2025Q2: Δ-6 · h=80 2025Q3: Δ+0 · h=80 2025Q4: Δ+19 · h=99 2026Q1: Δ+6 · h=105 2020Q1: holders=1 2023Q1: holders=30 2023Q2: holders=29 2023Q3: holders=28 2023Q4: holders=35 2024Q1: holders=83 2024Q2: holders=108 2024Q3: holders=108 2024Q4: holders=101 2025Q1: holders=86 2025Q2: holders=80 2025Q3: holders=80 2025Q4: holders=99 2026Q1: holders=105 -48 -24 +0 +24 +48 057114 20Q123Q123Q223Q323Q424Q124Q224Q324Q425Q125Q225Q325Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 3 lit events

Period Percentile Next-1Q return Next-2Q return
2024Q2 Top 10% -67.2% -85.4%
2024Q1 Top 4% +29.3% -63.1%
2023Q1 Top 5% — —

Options Sentiment

Put holders
2
QoQ: +2
Call holders
6
QoQ: +4

See methodology →

Fundamentals

PE (TTM)
—
EPS (TTM)
$-5.74
EPS YoY
—
Revenue (TTM)
—
Revenue YoY
—
Quarterly Revenue & EPS (4Y)
2024-03-31: EPS -0.83 2024-06-30: EPS -0.90 2024-09-30: EPS -1.15 2024-12-31: EPS -0.80 2025-03-31: EPS -1.39 2025-06-30: EPS -1.44 2025-09-30: EPS -1.90 2025-12-31: EPS -1.17 2026-03-31: EPS -1.23 -2.09 -1.04 0.00 20222023202420252026 EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

As of 2026-03-31 · SEC filings (XBRL)